Advanced search
1 file | 55.72 KB Add to list

Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study

(2009) JOURNAL OF UROLOGY. 181(1). p.410-410
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 55.72 KB

Citation

Please use this url to cite or link to this publication:

MLA
Sylvester, RJ, et al. “Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study.” JOURNAL OF UROLOGY, vol. 181, no. 1, ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, 2009, pp. 410–410, doi:10.1016/j.juro.2008.09.053.
APA
Sylvester, R., Oosterlinck, W., & O’Donnell, M. (2009). Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study. JOURNAL OF UROLOGY, 181(1), 410–410. https://doi.org/10.1016/j.juro.2008.09.053
Chicago author-date
Sylvester, RJ, Willem Oosterlinck, and M O’Donnell. 2009. “Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study.” JOURNAL OF UROLOGY 181 (1): 410–410. https://doi.org/10.1016/j.juro.2008.09.053.
Chicago author-date (all authors)
Sylvester, RJ, Willem Oosterlinck, and M O’Donnell. 2009. “Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study.” JOURNAL OF UROLOGY 181 (1): 410–410. doi:10.1016/j.juro.2008.09.053.
Vancouver
1.
Sylvester R, Oosterlinck W, O’Donnell M. Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study. JOURNAL OF UROLOGY. 2009;181(1):410–410.
IEEE
[1]
R. Sylvester, W. Oosterlinck, and M. O’Donnell, “Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study,” JOURNAL OF UROLOGY, vol. 181, no. 1, pp. 410–410, 2009.
@article{526239,
  author       = {{Sylvester, RJ and Oosterlinck, Willem and O'Donnell, M}},
  issn         = {{0022-5347}},
  journal      = {{JOURNAL OF UROLOGY}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{410--410}},
  publisher    = {{ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH}},
  title        = {{Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study}},
  url          = {{http://doi.org/10.1016/j.juro.2008.09.053}},
  volume       = {{181}},
  year         = {{2009}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: